Lv3
346 积分 2023-12-05 加入
Safety and Tolerability of c-MET Inhibitors in Cancer
14天前
已完结
THE GASTROINTESTINAL ABSORPTION OF ORAL IRON-DEXTRAN AND FERROUS SULFATE
29天前
已完结
Development of a Crohn's Disease Activity Index
1个月前
已完结
Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
3个月前
已完结
[Evaluation considerations for using surrogate endpoints in anticancer clinical trials]
3个月前
已完结
SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant
4个月前
已完结
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
4个月前
已完结
Resistance mechanisms to osimertinib in EGFR-mutated non-small cell lung cancer
4个月前
已完结
Navigating the landscape of EGFR TKI resistance in EGFR-mutant NSCLC — mechanisms and evolving treatment approaches
6个月前
已完结
Navigating the Evolving Landscape of EGFR -Mutated NSCLC
6个月前
已完结
皖公网安备34019202002308
